Knowledge is power with new cancer test
Medtech start-up Atturos is preparing to bring to market a blood test that could help men diagnosed with prostate cancer avoid undergoing unnecessary surgery. “The lead product we have in development is a test for men who have been diagnosed with low to intermediate prostate cancer,” said David Corr, chief executive of Atturos. “They have to decide whether to opt for surgery and radiotherapy or go on to an active surveillance programme. These treatment options...
Subscribe from just 1€
Choose the subscription that is right for you
For the first month
€19.99 Monthly ThereafterSubscribe today
For the first year
€199.99 annually thereafterSubscribe today
For the first 90 days
€55.00 quarterly ThereafterSubscribe today
These offers are not available for current subscribers. Offers and pricing are subject to change without notice.
Terms & Conditions Apply